mometamax

MMometamax Otic Suspension is indicated for the treatment of canine otitis externa in dogs caused by susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Pseudomonas spp. [including P. aeruginosa], coagulase-positive staphylococci, Enterococcus faecalis, Proteus mirabilis, and beta-hemolytic streptococci).

Each gram of MMometamax Otic Suspension contains gentamicin sulfate, USP equivalent to 3 mg gentamicin base; mometasone furoate monohydrate equivalent to 1 mg mometasone; and 10 mg clotrimazole, USP in a mineral oil-based system containing a plasticized hydrocarbon gel.

Dosage and Administration

The external ear canal should be thoroughly cleaned and dried before treatment. Verify that the eardrum is intact. For dogs weighing less than 30 lbs, instill 4 drops from the 7.5 g, 15 g, OR 30 g bottles of MMometamax Otic Suspension once daily into the ear canal. For dogs weighing 30 lbs or more, instill 8 drops from the 7.5 g, 15 g, OR 30 g bottles once daily into the ear canal. Therapy should continue for 7 consecutive days.

Features and Benefits

• Convenient SID dosing regardless of otitis externa severity2
• As few as 4 drops required at administration2
• Easier for clients, less stressful for dogs than BID
• Helps promote client compliance to ensure treatment success
• Extensively proven in adult and pediatric human dermatology and allergy1
• Highly effective relief from atopy, a primary precipitant of otitis externa
• 7.7 times more potent than betamethasone1
• Safety profile comparable to betamethasone1
• No corticosteroid-related side effects observed in canine clinical trials1
• Clotrimazole - The #1 otic antifungal1
• Superior antifungal potency to Nystatin®* confirmed in a recent national study